SyntekaBio,Inc. Logo

SyntekaBio,Inc.

AI drug discovery platform accelerating R&D with supercomputing, SaaS, and pre-made candidates.

226330 | KO

Overview

Corporate Details

ISIN(s):
KR7226330009
LEI:
Country:
South Korea
Address:
대전광역시 유성구 국제과학17로 18 -, 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SyntekaBio is an AI-driven drug discovery company that utilizes its proprietary supercomputing infrastructure to accelerate the development of therapeutics. The company's core platform, DeepMatcher®, automates the process of identifying and optimizing drug candidates from hit screening to preclinical lead generation. SyntekaBio offers its technology through several business models: STB LaunchPad, a repository of pre-made, 'off-the-shelf' drug candidates for over 100 disease targets; end-to-end discovery and development services; and a suite of CLOUD-SaaS modules for specific applications like small molecule analysis (Sm-ARS), neoantigen prediction (NEO-ARS), and antibody design (Ab-ARS). This 'factory-like' approach aims to reduce the time and cost of pharmaceutical R&D for its partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 64.1 KB
2025-09-15 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.9 KB
2025-09-12 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 85.9 KB
2025-09-12 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-09-12 00:00
Capital/Financing Update
단기차입금감소결정(자율공시)
Korean 7.0 KB
2025-09-12 00:00
Major Shareholding Notification
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Korean 12.4 KB
2025-09-12 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 30.4 KB
2025-09-12 00:00
Registration Form
증권신고서(지분증권) (2025.12)
Korean 2.4 MB
2025-09-03 00:00
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
Korean 79.9 KB
2025-09-03 00:00
Capital/Financing Update
단기차입금증가결정
Korean 9.1 KB
2025-08-26 00:00
Capital/Financing Update
주요사항보고서(자기전환사채매도결정)
Korean 29.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 97.1 KB
2025-07-21 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 9.7 KB
2025-07-15 00:00
Regulatory News Service
본점소재지변경
Korean 5.0 KB

Automate Your Workflow. Get a real-time feed of all SyntekaBio,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SyntekaBio,Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SyntekaBio,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.